Navigation Links
Cancer Research UK's new funding scheme to nurture future world-leading scientists
Date:7/2/2014

A NEW funding scheme will support mid-career scientists looking to take the next steps in their careers, at a point when funding opportunities can be limited.

Cancer Research UK's Programme Foundation Award* will bridge the gap for researchers who have the potential to be the next world-leaders in cancer research but not yet at the level to compete with senior scientists for Cancer Research UK's Programme Awards the largest award Cancer Research UK makes to research groups.

This award is the first of Cancer Research UK's increased investment in research announced as part of its new research strategy.

The Programme Foundation Award will provide funding of up to 1.5 million over six years. The funding will cover staff salaries, PhD students, running costs and equipment. Typically a researcher will have around eight to 14 years post-doctoral experience when applying for the award.

Dr Iain Foulkes, Cancer Research UK's executive director of strategy and research funding, said: "Researchers are vital for what we do we rely on their curiosity, passion and questioning to make the breakthroughs that will help more people survive cancer. But for many years there has been a 'missing link' in funding schemes to take researchers from the early stages in their career to being the leading stars of cancer research. The Programme Foundation Award will bridge this gap."

Cancer Research UK is also changing the eligibility criteria for another of its awards the Career Establishment Award. This will now support researchers for six years, rather than five, meaning that there are funding opportunities for scientists at all stages of their careers with holders of the Career Establishment Awards expected to progress onto the Programme Foundation Award.

Supporting researchers at all stages of their careers has long been at the heart of Cancer Research UK's work with over 35 million spent each year helping to develop the research leaders of tomorrow. This month the charity supported the largest number ever of awards to support researchers taking the next steps in their careers. This includes seven Career Development Fellowships, two Career Establishment Awards, two Senior Cancer Research Fellowships and five Clinician Scientist Fellowships.

The Programme Foundation Award forms part of Cancer Research UK's ambitious new research strategy. The charity will invest up to 50 million a year in a range of new funding schemes covering some of the biggest questions in cancer research. These will range from schemes to develop the next generation of researchers to those addressing specific research questions to improve our understanding of the disease and find better and kinder treatments.

Professor Nic Jones, Cancer Research UK's chief scientist, said: "The new Programme Foundation Award positions the UK as one of the best places in the world for a scientist to develop their career in cancer research. We want to recruit the best people and help them grow at every step of their career. The medical breakthroughs of tomorrow start with investment in today's cancer researchers. This is how we will get to our aim of getting three-quarters of people surviving cancer in the next 20 years."


'/>"/>

Contact: Simon Shears
simon.shears@cancer.org.uk
44-203-469-8054
Cancer Research UK
Source:Eurekalert

Related medicine news :

1. Biomarker predicts effectiveness of brain cancer treatment
2. GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer
3. For cancer patients, sugar-coated cells are deadly
4. Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
5. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
6. Enlightening cancer cells
7. Cancer risk: Aspirin and smoking affect aging of genes
8. EORTC presents European solution for effective cancer drug development
9. New approach identifies cancer mutations as targets of effective melanoma immunotherapy
10. Case Western Reserve, University Hospitals fundraising for adolescent, young adult cancer
11. Improved survival with TAS-102 in mets colorectal cancer refractory to standard therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: